- Home
- ONFO vs NDRA Comparison
ONFO vs NDRA Comparison
Compare ONFO & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- NDRA
- Stock Information
- Founded
- ONFO 2018
- NDRA 2007
- Country
- ONFO United States
- NDRA United States
- Employees
- ONFO N/A
- NDRA N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ONFO Technology
- NDRA Health Care
- Exchange
- ONFO Nasdaq
- NDRA Nasdaq
- Market Cap
- ONFO 4.5M
- NDRA 5.1M
- IPO Year
- ONFO 2022
- NDRA 2017
- Fundamental
- Price
- ONFO $1.30
- NDRA $4.54
- Analyst Decision
- ONFO
- NDRA Strong Buy
- Analyst Count
- ONFO 0
- NDRA 1
- Target Price
- ONFO N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- ONFO 24.9K
- NDRA 709.8K
- Earning Date
- ONFO 11-15-2024
- NDRA 11-15-2024
- Dividend Yield
- ONFO N/A
- NDRA N/A
- EPS Growth
- ONFO N/A
- NDRA N/A
- EPS
- ONFO N/A
- NDRA N/A
- Revenue
- ONFO $6,590,171.00
- NDRA N/A
- Revenue This Year
- ONFO $133.59
- NDRA N/A
- Revenue Next Year
- ONFO N/A
- NDRA N/A
- P/E Ratio
- ONFO N/A
- NDRA N/A
- Revenue Growth
- ONFO 29.25
- NDRA N/A
- 52 Week Low
- ONFO $0.39
- NDRA $4.41
- 52 Week High
- ONFO $1.80
- NDRA $4,882.50
- Technical
- Relative Strength Index (RSI)
- ONFO 58.89
- NDRA 31.46
- Support Level
- ONFO $1.04
- NDRA $5.23
- Resistance Level
- ONFO $1.15
- NDRA $8.80
- Average True Range (ATR)
- ONFO 0.13
- NDRA 1.58
- MACD
- ONFO -0.01
- NDRA -0.06
- Stochastic Oscillator
- ONFO 62.00
- NDRA 1.73
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.